Lipopolysaccharide-induced and ischemia-reperfusion-mediated ALI in rodents have revealed pharmacologic inhibition of Src phosphorylation by Src inhibitors suppressed neutrophil influx, upregulated MMP-9 mRNA expression, and MIP-2 production [21, 23]. The gene discussed is MMP9; the disease is ischemia.